0001193125-22-142286.txt : 20220506 0001193125-22-142286.hdr.sgml : 20220506 20220505160625 ACCESSION NUMBER: 0001193125-22-142286 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220505 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Walgreens Boots Alliance, Inc. CENTRAL INDEX KEY: 0001618921 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 471758322 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36759 FILM NUMBER: 22896181 BUSINESS ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: (847) 315-2500 MAIL ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 8-K 1 d358573d8k.htm 8-K 8-K
false 0001618921 0001618921 2022-05-05 2022-05-05 0001618921 us-gaap:CommonStockMember 2022-05-05 2022-05-05 0001618921 wba:A3600NotesPayableDue2025Member 2022-05-05 2022-05-05 0001618921 wba:A3450NotesPayableDue2026Member 2022-05-05 2022-05-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 5, 2022

 

 

WALGREENS BOOTS ALLIANCE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36759   47-1758322

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification Number)

 

108 Wilmot Road, Deerfield, Illinois   60015
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (847) 315-2500

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.01 par value   WBA   The Nasdaq Stock Market LLC
3.600% Walgreens Boots Alliance, Inc. notes due 2025   WBA25   The Nasdaq Stock Market LLC
2.125% Walgreens Boots Alliance, Inc. notes due 2026   WBA26   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 8.01. Other Events

Walgreen Co. (“Walgreens”), a subsidiary of Walgreens Boots Alliance, Inc. (together with Walgreens, the “Company”), issued a press release today announcing that it has entered into a settlement agreement with the State of Florida to resolve claims related to prescriptions for opioid medications that were filled at Walgreens pharmacy locations in Florida. Under the terms of the settlement agreement, the Company will settle all opioid claims against it by the State of Florida for $683 million, which includes $620 million to be paid to the State of Florida over 18 years as well as a one-time payment of $63 million for attorneys’ fees. The settlement includes no admission of wrongdoing or liability by the Company.

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

   

Description

99.1    Press Release of Walgreens Boots Alliance, Inc. dated May 5, 2022
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

Cautionary Note Regarding Forward-Looking Statements

All statements in this report that are not historical including, without limitation, those regarding payments anticipated to be made pursuant to the settlement agreement, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “will,” “likely,” “intend,” “plan,” “aim,” “continue,” “believe,” “seek,” “anticipate,” “upcoming,” “may,” “possible,” and variations of such words and similar expressions are intended to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended August 31, 2021 and in other documents that we file or furnish with the Securities and Exchange Commission. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All forward-looking statements we make or that are made on our behalf are qualified by these cautionary statements. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    WALGREENS BOOTS ALLIANCE, INC.
Date: May 5, 2022     By:  

/s/ Joseph B. Amsbary, Jr.

    Title:   Vice President and Corporate Secretary
 EX-99.1 2 d358573dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Walgreens Reaches Opioid Settlement with State of Florida

DEERFIELD, Ill—May 5, 2022 – Walgreens today announced that it has entered into an agreement with the State of Florida to resolve all claims related to the distribution and dispensing of prescription opioid medications across the company’s pharmacies in the state.

The settlement amount of $683 million includes $620 million to be paid out to the State of Florida over 18 years, as well as a one-time payment of $63 million for attorneys’ fees.

The settlement includes no admission of wrongdoing or liability by Walgreens.

“As the largest pharmacy chain in the state, we remain focused on and committed to being part of the solution, and believe this resolution is in the best interest of all parties involved and the communities we serve across Florida,” said Danielle Gray, executive vice president and global chief legal officer, Walgreens Boots Alliance, Inc. “Our pharmacists are dedicated healthcare professionals who live and work in the communities they serve, and play a critical role in providing education and resources to help combat opioid misuse and abuse.”

As one of Florida’s leading healthcare providers, Walgreens has taken a number of actions to prevent and respond to the opioid crisis, while continuing to serve patients, including:

 

  •  

Providing patient education on safe opioid use

 

  •  

Making life-saving Naloxone, the opioid overdose reversal medication, available in all Walgreens pharmacies nationwide

 

  •  

Providing safe and convenient medication disposal kiosks available at 1,400 Walgreens stores, along with other safe disposal options at all other Walgreens locations

 

  •  

Deploying technology to help pharmacists ensure they are dispensing prescriptions written for a legitimate medical purpose

 

  •  

Stopping self-distribution of opioids and all pharmaceuticals to Walgreens stores in 2014

The settlement funds will be used by the State of Florida to support its efforts to combat and treat opioid addiction. The settlement is a result of unique facts and circumstances concerning the state of Florida. It should not be used to forecast or predict the value of any other litigation claims or future settlements, and is unrelated to any other opioid-related litigation in which Walgreens is involved and which the company will continue to defend vigorously.

About Walgreens

Walgreens (www.walgreens.com) is included in the United States segment of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and well-being of every community in America. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 9 million customers each day. Walgreens pharmacists play a critical role in the U.S.

healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in local communities nationwide.

Contact

Fraser Engerman

fraser.engerman@walgreens.com

EX-101.SCH 3 wba-20220505.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 wba-20220505_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 wba-20220505_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Common Stock [Member] A 3600 Notes Payable Due 2025 [Member] A 3600 Notes Payable Due 2025 [Member] A 3450 Notes Payable Due 2026 [Member] A 3450 Notes Payable Due 2026 [Member] EX-101.PRE 6 wba-20220505_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g358573g0505214433103.jpg GRAPHIC begin 644 g358573g0505214433103.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
May 05, 2022
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001618921
Document Type 8-K
Document Period End Date May 05, 2022
Entity Registrant Name WALGREENS BOOTS ALLIANCE, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-36759
Entity Tax Identification Number 47-1758322
Entity Address, Address Line One 108 Wilmot Road
Entity Address, City or Town Deerfield
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60015
City Area Code (847)
Local Phone Number 315-2500
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Common Stock, $0.01 par value
Trading Symbol WBA
Security Exchange Name NASDAQ
A 3600 Notes Payable Due 2025 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 3.600% Walgreens Boots Alliance, Inc. notes due 2025
Trading Symbol WBA25
Security Exchange Name NASDAQ
A 3450 Notes Payable Due 2026 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 2.125% Walgreens Boots Alliance, Inc. notes due 2026
Trading Symbol WBA26
Security Exchange Name NASDAQ
XML 9 d358573d8k_htm.xml IDEA: XBRL DOCUMENT 0001618921 2022-05-05 2022-05-05 0001618921 us-gaap:CommonStockMember 2022-05-05 2022-05-05 0001618921 wba:A3600NotesPayableDue2025Member 2022-05-05 2022-05-05 0001618921 wba:A3450NotesPayableDue2026Member 2022-05-05 2022-05-05 false 0001618921 8-K 2022-05-05 WALGREENS BOOTS ALLIANCE, INC. DE 001-36759 47-1758322 108 Wilmot Road Deerfield IL 60015 (847) 315-2500 false false false false Common Stock, $0.01 par value WBA NASDAQ 3.600% Walgreens Boots Alliance, Inc. notes due 2025 WBA25 NASDAQ 2.125% Walgreens Boots Alliance, Inc. notes due 2026 WBA26 NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 4 22 1 false 3 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d358573d8k.htm d358573dex991.htm wba-20220505.xsd wba-20220505_def.xml wba-20220505_lab.xml wba-20220505_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d358573d8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "wba-20220505_def.xml" ] }, "inline": { "local": [ "d358573d8k.htm" ] }, "labelLink": { "local": [ "wba-20220505_lab.xml" ] }, "presentationLink": { "local": [ "wba-20220505_pre.xml" ] }, "schema": { "local": [ "wba-20220505.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 2, "memberStandard": 1, "nsprefix": "wba", "nsuri": "http://walgreensbootsalliance.com/20220505", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d358573d8k.htm", "contextRef": "duration_2022-05-05_to_2022-05-05", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d358573d8k.htm", "contextRef": "duration_2022-05-05_to_2022-05-05", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "wba_A3450NotesPayableDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "A 3450 Notes Payable Due 2026 [Member]", "terseLabel": "A 3450 Notes Payable Due 2026 [Member]" } } }, "localname": "A3450NotesPayableDue2026Member", "nsuri": "http://walgreensbootsalliance.com/20220505", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "wba_A3600NotesPayableDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "A 3600 Notes Payable Due 2025 [Member]", "terseLabel": "A 3600 Notes Payable Due 2025 [Member]" } } }, "localname": "A3600NotesPayableDue2025Member", "nsuri": "http://walgreensbootsalliance.com/20220505", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "wba_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://walgreensbootsalliance.com/20220505", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "wba_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://walgreensbootsalliance.com/20220505", "presentation": [ "http://walgreensbootsalliance.com//20220505/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001193125-22-142286-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-142286-xbrl.zip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